E12 Ventures is an early-stage venture capital firm that invests in companies tackling global industry challenges with emerging technologies like Artificial Intelligence, Data Infrastructure, Robotics, Computer Vision, and Health. Their strategy involves closely collaborating with founders to develop and execute winning strategies, leveraging their extensive networks and operational expertise to support companies in sectors ripe for disruption.
50% of their portfolio is in Healthcare. Deal activity increased 200% year-over-year (3 deals in the last 12 months). Their most common stage is series-a (75% of deals). Average disclosed round size is $25.5M (across 3 rounds with reported amounts).
Portfolio
4
Fund Size
$105M
Top Stage
Series A
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Neura Health | Series A | $11.4M | Sep 2025 |
| TTelo | Series A | $20M | Sep 2025 |
 Ellipsis Health | Series A | $45M | Jun 2025 |
 First Resonance | Unknown | — | Dec 2024 |
Top Co-Investors
Last updated: 15 April 2026